Anti-HCV, nucleotide inhibitors, repurposing against COVID-19.
Identifieur interne : 000584 ( Main/Exploration ); précédent : 000583; suivant : 000585Anti-HCV, nucleotide inhibitors, repurposing against COVID-19.
Auteurs : Abdo A. Elfiky [Arabie saoudite]Source :
- Life sciences [ 1879-0631 ] ; 2020.
Abstract
A newly emerged Human Coronavirus (HCoV) is reported two months ago in Wuhan, China (COVID-19). Until today >2700 deaths from the 80,000 confirmed cases reported mainly in China and 40 other countries. Human to human transmission is confirmed for COVID-19 by China a month ago. Based on the World Health Organization (WHO) reports, SARS HCoV is responsible for >8000 cases with confirmed 774 deaths. Additionally, MERS HCoV is responsible for 858 deaths out of about 2500 reported cases. The current study aims to test anti-HCV drugs against COVID-19 RNA dependent RNA polymerase (RdRp).
DOI: 10.1016/j.lfs.2020.117477
PubMed: 32119961
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000350
- to stream PubMed, to step Curation: 000350
- to stream PubMed, to step Checkpoint: 000553
- to stream Ncbi, to step Merge: 000A62
- to stream Ncbi, to step Curation: 000A62
- to stream Ncbi, to step Checkpoint: 000A62
- to stream Main, to step Merge: 000586
- to stream Main, to step Curation: 000584
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Anti-HCV, nucleotide inhibitors, repurposing against COVID-19.</title>
<author><name sortKey="Elfiky, Abdo A" sort="Elfiky, Abdo A" uniqKey="Elfiky A" first="Abdo A" last="Elfiky">Abdo A. Elfiky</name>
<affiliation wicri:level="1"><nlm:affiliation>Biophysics Department, Faculty of Sciences, Cairo University, Giza, Egypt; College of Applied Medical Sciences, University of Al-Jouf, Saudi Arabia. Electronic address: abdo@sci.cu.edu.eg.</nlm:affiliation>
<country xml:lang="fr">Arabie saoudite</country>
<wicri:regionArea>Biophysics Department, Faculty of Sciences, Cairo University, Giza, Egypt; College of Applied Medical Sciences, University of Al-Jouf</wicri:regionArea>
<wicri:noRegion>University of Al-Jouf</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32119961</idno>
<idno type="pmid">32119961</idno>
<idno type="doi">10.1016/j.lfs.2020.117477</idno>
<idno type="wicri:Area/PubMed/Corpus">000350</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000350</idno>
<idno type="wicri:Area/PubMed/Curation">000350</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000350</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000553</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000553</idno>
<idno type="wicri:Area/Ncbi/Merge">000A62</idno>
<idno type="wicri:Area/Ncbi/Curation">000A62</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000A62</idno>
<idno type="wicri:Area/Main/Merge">000586</idno>
<idno type="wicri:Area/Main/Curation">000584</idno>
<idno type="wicri:Area/Main/Exploration">000584</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Anti-HCV, nucleotide inhibitors, repurposing against COVID-19.</title>
<author><name sortKey="Elfiky, Abdo A" sort="Elfiky, Abdo A" uniqKey="Elfiky A" first="Abdo A" last="Elfiky">Abdo A. Elfiky</name>
<affiliation wicri:level="1"><nlm:affiliation>Biophysics Department, Faculty of Sciences, Cairo University, Giza, Egypt; College of Applied Medical Sciences, University of Al-Jouf, Saudi Arabia. Electronic address: abdo@sci.cu.edu.eg.</nlm:affiliation>
<country xml:lang="fr">Arabie saoudite</country>
<wicri:regionArea>Biophysics Department, Faculty of Sciences, Cairo University, Giza, Egypt; College of Applied Medical Sciences, University of Al-Jouf</wicri:regionArea>
<wicri:noRegion>University of Al-Jouf</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Life sciences</title>
<idno type="eISSN">1879-0631</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">A newly emerged Human Coronavirus (HCoV) is reported two months ago in Wuhan, China (COVID-19). Until today >2700 deaths from the 80,000 confirmed cases reported mainly in China and 40 other countries. Human to human transmission is confirmed for COVID-19 by China a month ago. Based on the World Health Organization (WHO) reports, SARS HCoV is responsible for >8000 cases with confirmed 774 deaths. Additionally, MERS HCoV is responsible for 858 deaths out of about 2500 reported cases. The current study aims to test anti-HCV drugs against COVID-19 RNA dependent RNA polymerase (RdRp).</div>
</front>
</TEI>
<affiliations><list><country><li>Arabie saoudite</li>
</country>
</list>
<tree><country name="Arabie saoudite"><noRegion><name sortKey="Elfiky, Abdo A" sort="Elfiky, Abdo A" uniqKey="Elfiky A" first="Abdo A" last="Elfiky">Abdo A. Elfiky</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000584 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000584 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= CovidV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:32119961 |texte= Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32119961" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a CovidV1
This area was generated with Dilib version V0.6.33. |